 Janus Henderson Group PLC raised its position in Kalvista Pharmaceuticals Inc NASDAQ:KALV by 857.0 during the first quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 152,307 shares of the specialty pharmaceutical companys stock after buying an additional 136,392 shares during the period. Janus ... 